Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'BETA-ADRENOCEPTOR ANTAGONIST' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 127 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sharif, NA; Xu, SX; Crider, JY; McLaughlin, M; Davis, TL
      Levobetaxolol (Betaxon(TM)) and other beta-adrenergic antagonists: Preclinical pharmacology, IOP-lowering activity and sites of action in human eyes

      JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
    2. Melena, J; Stanton, D; Osborne, NN
      Comparative effects of antiglaucoma drugs on voltage-dependent calcium channels

      GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
    3. Goepel, M; Dinh, L; Mitchell, A; Schafers, RF; Rubben, H; Michel, MC
      Do saw palmetto extracts block human alpha(1)-adrenoceptor subtypes in vivo?

      PROSTATE
    4. Letienne, R; Vie, B; Puech, A; Vieu, S; Le Grand, B; John, GW
      Evidence that ranolazine behaves as a weak beta(1)- and beta(2)-adrenoceptor antagonist in the rat cardiovascular system

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    5. Oliveira, PJ; Rolo, AP; Sardao, VA; Coxito, PM; Palmeira, CM; Moreno, AJM
      Carvedilol in heart mitochondria - Protonophore or opener of the mitochondrial K-ATP channels?

      LIFE SCIENCES
    6. Luchowska, E; Luchowski, P; Wielosz, M; Kleinrok, Z; Urbanska, EM
      beta-adrenoceptor blockade enhances the anticonvulsant effect of glutamatereceptor antagonists against maximal electroshock

      EUROPEAN JOURNAL OF PHARMACOLOGY
    7. Bundkirchen, A; Brixius, K; Bolck, B; Mehlhorn, U; Bloch, W; Schwinger, RHG
      Nebivolol, carvedilol and metoprolol do not influence cardiac Ca2+ sensitivity

      EUROPEAN JOURNAL OF PHARMACOLOGY
    8. Noda, K; Oka, M; Ma, FH; Kitazawa, S; Ukai, Y; Toda, N
      Release of endothelial nitric oxide in coronary arteries by celiprolol, a beta(1)-adrenoceptor antagonist: possible clinical relevance

      EUROPEAN JOURNAL OF PHARMACOLOGY
    9. Oliveira, PJ; Coxito, PM; Rolo, AP; Santos, DL; Palmeira, CM; Moreno, AJM
      Inhibitory effect of carvedilol in the high-conductance state of the mitochondrial permeability transition pore

      EUROPEAN JOURNAL OF PHARMACOLOGY
    10. Horio, T; Ito, S; Aoyama, M; Takeda, Y; Suzumura, H; Nakata, K; Yamada, Y; Suzuki, S; Fukutomi, T; Itoh, M
      Effect of carvedilol on atrioventricular conduction in the ischemic heart

      EUROPEAN JOURNAL OF PHARMACOLOGY
    11. Karle, CA; Kreye, VAW; Thomas, D; Rockl, K; Kathofer, S; Zhang, W; Kiehn, J
      Antiarrhythmic drug carvedilol inhibits HERG potassium channels

      CARDIOVASCULAR RESEARCH
    12. Oettl, K; Greilberger, J; Zangger, K; Haslinger, E; Reibnegger, G; Jurgens, G
      Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity

      BIOCHEMICAL PHARMACOLOGY
    13. Santos, DJSL; Moreno, AJM
      Inhibition of heart mitochondrial lipid peroxidation by non-toxic concentrations of carvedilol and its analog BM-910228

      BIOCHEMICAL PHARMACOLOGY
    14. Silke, B; Hanratty, CG; Veres, SM; Riddell, JG
      beta-adrenoceptor modulation and heart rate variability - The value of scatterplot measures of compactness

      CARDIOVASCULAR DRUGS AND THERAPY
    15. Wu, BN; Shen, KP; Lin, RJ; Huang, YC; Chiang, LC; Lo, YC; Lin, CY; Chen, IJ
      Lipid solubility of vasodilatory vanilloid-type beta-blockers on the functional and binding activities of beta-adrenoceptor subtypes

      GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM
    16. Muller, FU; Neumann, J; Schmitz, W
      Transcriptional regulation by cAMP in the heart

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    17. Farsang, C; Garcia-Puig, J; Niegowska, J; Baiz, AQ; Vrijens, F; Bortman, G
      The efficacy and tolerability of losartan versus atenolol in patients withisolated systolic hypertension

      JOURNAL OF HYPERTENSION
    18. Ohta, Y; Watanabe, K; Nakazawa, M; Yamamoto, T; Ma, ML; Fuse, K; Ito, M; Hirono, S; Tanabe, N; Hanawa, H; Kato, K; Kodama, M; Aizawa, Y
      Carvedilol enhances atrial and brain natriuretic peptide mRNA expression and release in rat heart

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    19. Lysko, PG; Webb, CL; Gu, JL; Ohlstein, EH; Ruffolo, RR; Yue, TL
      A comparison of carvedilol and metoprolol antioxidant activities in vitro

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    20. Kurz, T; Richardt, D; Gorge, B; Hartmann, F; Tolg, R; Katus, HA; Richardt, G
      Differential effects of carvedilol on norepinephrine release in normoxic and ischemic heart

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    21. Intengan, HD; Schiffrin, EL
      Disparate effects of carvedilol versus metoprolol treatment of stroke-prone spontaneously hypertensive rats on endothelial function of resistance arteries

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    22. Yeh, JL; Liou, SF; Liang, JC; Huang, YC; Chiang, LC; Wu, JR; Lin, YT; Chen, IJ
      Vanidipinedilol: A vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    23. Abreu, RMV; Santos, DJSL; Moreno, AJM
      Effects of carvedilol and its analog BM-910228 on mitochondrial function and oxidative stress

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    24. Gao, F; Chen, J; Lopez, BL; Christopher, TA; Gu, JL; Lysko, P; Ruffolo, RR; Ohlstein, EH; Ma, XL; Yue, TL
      Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model

      EUROPEAN JOURNAL OF PHARMACOLOGY
    25. Cargnoni, A; Ceconi, C; Bernocchi, P; Boraso, A; Parrinello, G; Curello, S; Ferrari, R
      Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability

      CARDIOVASCULAR RESEARCH
    26. Dudley, AJ; Bleasby, K; Brown, CDA
      The organic cation transporter OCT2 mediates the uptake of beta-adrenoceptor antagonists across the apical membrane of renal LLC-PK1 cell monolayers

      BRITISH JOURNAL OF PHARMACOLOGY
    27. Watanabe, K; Ohta, Y; Nakazawa, M; Higuchi, H; Hasegawa, G; Naito, M; Fuse, K; Ito, M; Hirono, S; Tanabe, N; Hanawa, H; Kato, K; Kodama, M; Aizawa, Y
      Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy

      BRITISH JOURNAL OF PHARMACOLOGY
    28. Chidlow, G; Melena, J; Osborne, NN
      Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na+ influx into cortical synaptosomes by direct interaction with Na+ channels: comparison with other beta-adrenoceptor antagonists

      BRITISH JOURNAL OF PHARMACOLOGY
    29. Yoshioka, T; Iwamoto, N; Tsukahara, F; Irie, K; Urakawa, I; Muraki, T
      Anti-NO action of carvedilol in cell-free system and in vascular endothelial cells

      BRITISH JOURNAL OF PHARMACOLOGY
    30. Oliveira, PJ; Marques, MPM; de Carvalho, LAEB; Moreno, AJM
      Effects of carvedilol on isolated heart mitochondria: Evidence for a protonophoretic mechanism

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    31. Liang, YL; Gatzka, CD; Du, XJ; Cameron, JD; Kingwell, BA; Dart, AM
      Effects of heart rate on arterial compliance in men

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    32. Andre, C; Couton, D; Gaston, J; Erraji, L; Renia, L; Varlet, P; Briand, P; Guillet, JG
      beta(2)-adrenergic receptor-selective agonist clenbuterol prevents Fas-induced liver apoptosis and death in mice

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    33. Fink, B; Schwemmer, M; Fink, N; Bassenge, E
      Tolerance to nitrates with enhanced radical formation suppressed by carvedilol

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    34. Dobsak, P; Courderot-Masuyer, C; Zeller, M; Vergely, C; Laubriet, A; Assem, M; Eicher, JC; Teyssier, JR; Wolf, JE; Rochette, L
      Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    35. Holtback, U; Eklof, AC
      Mechanism of FK 506/520 action on rat renal proximal tubular Na+,K+-ATPaseactivity

      KIDNEY INTERNATIONAL
    36. Kaan, SK; Cho, CH
      Study of propranolol and its related adrenoceptor antagonists on changes of gastric electrical parameters induced by ethanol in rats

      PHARMACOLOGY
    37. Willette, RN; Aiyar, N; Yue, TL; Mitchell, MP; Disa, J; Storer, BL; Naselsky, DP; Stadel, JM; Ohlstein, EH; Ruffolo, RR
      In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    38. Lin, YT; Wu, BN; Horng, CF; Huang, YC; Hong, SJ; Lo, YC; Cheng, CJ; Chen, IJ
      Isoeugenolol: A selective beta(1)-adrenergic antagonist with tracheal and vascular smooth muscle relaxant properties

      JAPANESE JOURNAL OF PHARMACOLOGY
    39. Kawarai, A; Koss, MC
      Sympathetic vasodilation in the rat anterior choroid mediated by beta(1)-adrenoceptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    40. Melena, J; Wood, JPM; Osborne, NN
      Betaxolol, a beta(1)-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels

      EUROPEAN JOURNAL OF PHARMACOLOGY
    41. Christensen, JD; Hansen, EW; Frederiksen, C; Molris, M; Moesby, L
      Adrenaline influences the release of interleukin-6 from murine pituicytes:role of beta(2)-adrenoceptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    42. Cheng, JH; Niwa, R; Kamiya, K; Toyama, J; Kodama, I
      Carvedilol blocks the repolarizing K+ currents and the L-type Ca2+ currentin rabbit ventricular myocytes

      EUROPEAN JOURNAL OF PHARMACOLOGY
    43. Janssen, PML; Zeitz, O; Hasenfuss, G
      Transient and sustained impacts of hydroxyl radicals on sarcoplasmic reticulum function: protective effects of nebivolol

      EUROPEAN JOURNAL OF PHARMACOLOGY
    44. Cleland, JGF
      Progression from hypertension to heart failure - Mechanisms and management

      CARDIOLOGY
    45. van der Does, R; Hauf-Zachariou, U; Pfarr, E; Holtbrugge, W; Konig, S; Griffiths, M; Lahiri, A
      Comparison of safety and efficacy of carvedilol and metoprolol in stable angina pectoris

      AMERICAN JOURNAL OF CARDIOLOGY
    46. CALDWELL GW; EASLICK SM; GUNNET J; MASUCCI JA; DEMAREST K
      IN-VITRO PERMEABILITY OF 8 BETA-BLOCKERS THROUGH CACO-2 MONOLAYERS UTILIZING LIQUID-CHROMATOGRAPHY ELECTROSPRAY-IONIZATION MASS-SPECTROMETRY

      Journal of mass spectrometry
    47. Mangrella, M; Rossi, F; Fici, F; Rossi, F
      Pharmacology of nebivolol

      PHARMACOLOGICAL RESEARCH
    48. HIGUCHI Y; ONO K; SEKITA S; ONODERA H; MITSUMORI K; NARA Y; SATAKE M
      PREVENTIVE EFFECTS OF SHICHIMOTSU-KOKA-TO ON RENAL LESIONS IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS

      Biological & pharmaceutical bulletin
    49. WATANABE H; KAKIHANA M; OHTSUKA S; SUGISHITA Y
      RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CARVEDILOL ON THE PREVENTION OF NITRATE TOLERANCE IN PATIENTS WITH CHRONIC HEART-FAILURE

      Journal of the American College of Cardiology
    50. BLESKE BE; GILBERT EM; MUNGER MA
      CARVEDILOL - THERAPEUTIC APPLICATION AND PRACTICE GUIDELINES

      Pharmacotherapy
    51. RUFFOLO RR; FEUERSTEIN GZ
      CARVEDILOL - PRECLINICAL PROFILE AND MECHANISMS OF ACTION IN PREVENTING THE PROGRESSION OF CONGESTIVE-HEART-FAILURE

      European heart journal
    52. FAZIO S; PALMIERI EA; FERRAVANTE B; BONE F; BIONDI B; SACCA L
      DOXORUBICIN-INDUCED CARDIOMYOPATHY TREATED WITH CARVEDILOL

      Clinical cardiology
    53. HOSTE AM; SYS SU
      CA2-BLOCKING ACTIVITY OF PROPRANOLOL AND BETAXOLOL IN ISOLATED BOVINERETINAL MICROARTERY( CHANNEL)

      Journal of cardiovascular pharmacology
    54. KHANDOUDI N; PERCEVAULTALBADINE J; BRIL A
      COMPARATIVE EFFECTS OF CARVEDILOL AND METOPROLOL ON CARDIAC ISCHEMIA-REPERFUSION INJURY

      Journal of cardiovascular pharmacology
    55. RUFFOLO RR; FEUERSTEIN GZ
      NEUROHORMONAL ACTIVATION, OXYGEN-FREE RADICALS, AND APOPTOSIS IN THE PATHOGENESIS OF CONGESTIVE-HEART-FAILURE

      Journal of cardiovascular pharmacology
    56. RITCHIE RH; SALLUSTIO BC; HII JTY; HOROWITZ JD
      SHORT-TERM MYOCARDIAL UPTAKE OF D-SOTALOL AND L-SOTALOL IN HUMANS - RELATION TO HEMODYNAMIC AND ELECTROPHYSIOLOGIC EFFECTS

      Journal of cardiovascular pharmacology
    57. WU BN; HUANG YC; WU HM; HONG SJ; CHIANG LC; CHEN IJ
      A HIGHLY SELECTIVE BETA(1)-ADRENERGIC BLOCKER WITH PARTIAL BETA(2)-AGONIST ACTIVITY DERIVED FROM FERULIC ACID, AN ACTIVE COMPONENT OF LIGUSTICUM-WALLICHII FRANCH

      Journal of cardiovascular pharmacology
    58. KITAORI K; FURUKAWA Y; YOSHIMOTO H; OTERA J
      CSF IN ORGANIC-SYNTHESIS - THE FIRST AND CONVENIENT SYNTHESIS OF ENANTIOPURE BISOPROLOL BY USE OF GLYCIDYL NOSYLATE

      Tetrahedron letters
    59. FEUERSTEIN G; YUE TL; MA XL; RUFFOLO RR
      NOVEL MECHANISMS IN THE TREATMENT OF HEART-FAILURE - INHIBITION OF OXYGEN RADICALS AND APOPTOSIS BY CARVEDILOL

      Progress in cardiovascular diseases
    60. EMILIEN G; MALOTEAUX JM
      CURRENT THERAPEUTIC USES AND POTENTIAL OF BETA-ADRENOCEPTOR AGONISTS AND ANTAGONISTS

      European Journal of Clinical Pharmacology
    61. Frishman, WH
      Carvedilol

      NEW ENGLAND JOURNAL OF MEDICINE
    62. MIGLIAVACCA E; ANCEREWICZ J; CARRUPT PA; TESTA B
      THEORETICAL PARAMETERS TO CHARACTERIZE ANTIOXIDANTS - PART 2 - THE CASES OF MELATONIN AND CARVEDILOL

      Helvetica chimica acta
    63. BRUNVAND H; LIU GL; MA XL; YUE TL; RUFFOLO RR; FEUERSTEIN GZ
      SB211475, A METABOLITE OF CARVEDILOL, REDUCES INFARCT SIZE AFTER MYOCARDIAL ISCHEMIC AND REPERFUSION INJURY IN RABBITS

      European journal of pharmacology
    64. FEUERSTEIN G; LIU GL; YUE TL; CHENG HY; HIEBLE JP; ARCH JRS; RUFFOLO RR; MA XL
      COMPARISON OF METOPROLOL AND CARVEDILOL PHARMACOLOGY AND CARDIOPROTECTION IN RABBIT ISCHEMIA AND REPERFUSION MODEL

      European journal of pharmacology
    65. YOSHIMOTO T; NARUSE M; IRIE K; TANABE A; SEKI T; TANAKA M; IMAKI T; NARUSE K; MURAKI T; MATSUDA Y; DEMURA H
      BETA-ADRENOCEPTOR ANTAGONIST PROPRANOLOL POTENTIATES HYPOTENSIVE ACTION OF NATRIURETIC PEPTIDES

      European journal of pharmacology
    66. YUE TL; MA XL; GU JL; RUFFOLO RR; FEUERSTEIN GZ
      CARVEDILOL INHIBITS ACTIVATION OF STRESS-ACTIVATED PROTEIN-KINASE ANDREDUCES REPERFUSION INJURY IN PERFUSED RABBIT HEART

      European journal of pharmacology
    67. LEBREC D
      MEDICAL DECOMPRESSIVE THERAPY FOR PROPHYLAXIS OF REBLEEDING

      Digestion
    68. OHASHI K; HAMAMURA T; LEE Y; FUJIWARA Y; KURODA S
      PROPRANOLOL ATTENUATES HALOPERIDOL-INDUCED FOS EXPRESSION IN DISCRETEREGIONS OF RAT-BRAIN - POSSIBLE BRAIN-REGIONS RESPONSIBLE FOR AKATHISIA

      Brain research
    69. Lysko, PG; Lysko, KA; Webb, CL; Feuerstein, G; Mason, PE; Walter, MF; Mason, RP
      Neuroprotective activities of carvedilol and a hydroxylated derivative - Role of membrane biophysical interactions

      BIOCHEMICAL PHARMACOLOGY
    70. HAUFZACHARIOU U; PFARR E; VANDERDOES R
      CARVEDILOL IN COMPARISON AND IN COMBINATION WITH ISOSORBIDE DINITRATESUSTAINED-RELEASE IN PATIENTS WITH CHRONIC STABLE EFFORT-INDUCED ANGINA-PECTORIS

      Clinical drug investigation
    71. RUFFOLO RR; FEUERSTEIN GZ
      PHARMACOLOGY OF CARVEDILOL - RATIONALE FOR USE IN HYPERTENSION, CORONARY-ARTERY DISEASE, AND CONGESTIVE-HEART-FAILURE

      Cardiovascular drugs and therapy
    72. KAIJSER M; JOHNSSON C; ZEZINA L; BACKMAN U; DIMENY E; FELLSTROM B
      ELEVATION OF CYCLOSPORINE-A BLOOD-LEVELS DURING CARVEDILOL TREATMENT IN RENAL-TRANSPLANT PATIENTS

      Clinical transplantation
    73. ABDELMAWLA AH; LANGLEY RW; SZABADI E; BRADSHAW CM
      BISOPROLOL ATTENUATES NORADRENALINE-EVOKED AND PHENYLEPHRINE-EVOKED VENOCONSTRICTION IN MAN IN-VIVO

      British journal of clinical pharmacology
    74. KAMALI F; HOWES A; THOMAS SHL; FORD GA; SNOECK E
      A PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION STUDY BETWEEN NEBIVOLOL AND THE H-2-RECEPTOR ANTAGONISTS CIMETIDINE AND RANITIDINE

      British journal of clinical pharmacology
    75. CHATELAIN P; MASSINGHAM R
      CARDIAC ISCHEMIA - POSSIBILITIES FOR FUTURE DRUG-THERAPY

      European journal of medicinal chemistry
    76. FEUERSTEIN GZ; FISHER M; NUNNARI J; RUFFOLO RR
      CARVEDILOL INHIBITS AORTIC LIPID DEPOSITION IN THE HYPERCHOLESTEROLEMIC RAT

      Pharmacology
    77. ROSS SB; STENFORS C
      THE FORGOTTEN 5-HYDROXYINDOLEACETIC ACID

      Journal of neurochemistry
    78. SATO Y; KUROSE H; NAGAO T
      RELATIONSHIP BETWEEN DESENSITIZATION AND DOWN-REGULATION OF BETA-ADRENOCEPTORS IN CARDIAC TISSUES AFTER PROLONGED IN-VIVO INFUSION OF T-0509, A BETA(1)-ADRENOCEPTOR AGONIST

      Japanese Journal of Pharmacology
    79. LI MY; REITH MEA
      EFFECT OF QUININE ON AUTORECEPTOR-REGULATED SEROTONIN RELEASE IN THE RAT HIPPOCAMPUS

      European journal of pharmacology
    80. DUNN CJ; LEA AP; WAGSTAFF AJ
      CARVEDILOL - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN CARDIOVASCULAR DISORDERS

      Drugs
    81. FEUERSTEIN GZ; BRIL A; RUFFOLO RR
      PROTECTIVE EFFECTS OF CARVEDILOL IN THE MYOCARDIUM

      The American journal of cardiology
    82. SCHMITZ W; BOKMIK P; LINCK B; MULLER FU
      ADRENERGIC AND MUSCARINIC RECEPTOR REGULATION AND THERAPEUTIC IMPLICATIONS IN HEART-FAILURE

      Molecular and cellular biochemistry
    83. WU BN; HO WC; CHIANG LC; CHEN IJ
      ZINGERONOLOL - A NEWLY DEVELOPED BETA-ADRENERGIC BLOCKING-AGENT DERIVED FROM ZINGERONE, A PUNGENT PRINCIPLE OF GINGER

      Asia Pacific journal of pharmacology
    84. BRUNVAND H; KVITTING PM; RYNNING SE; BERGE RK; GRONG K
      CARVEDILOL PROTECTS AGAINST LETHAL REPERFUSION INJURY THROUGH ANTIADRENERGIC MECHANISMS

      Journal of cardiovascular pharmacology
    85. JONKERS I; SWERUP C; PIRSKANEN R; BJELAK S; MATELL G
      ACUTE EFFECTS OF INTRAVENOUS-INJECTION OF BETA-ADRENOCEPTOR-ANTAGONISTS AND CALCIUM-CHANNEL-ANTAGONISTS AND AGONISTS IN MYASTHENIA-GRAVIS

      Muscle & nerve
    86. DARMANI NA; REEVES SL
      THE MECHANISM BY WHICH THE SELECTIVE 5-HT1A RECEPTOR ANTAGONIST S-(-)UH-301 PRODUCES HEAD-TWITCHES IN MICE

      Pharmacology, biochemistry and behavior
    87. PACKER M; BRISTOW MR; COHN JN; COLUCCI WS; FOWLER MB; GILBERT EM; SHUSTERMAN NH
      THE EFFECT OF CARVEDILOL ON MORBIDITY AND MORTALITY IN PATIENTS WITH CHRONIC HEART-FAILURE

      The New England journal of medicine
    88. BARONE FC; NELSON AH; OHLSTEIN EH; WILLETTE RN; SEALEY JE; LARAGH JH; CAMPBELL WG; FEUERSTEIN GZ
      CHRONIC CARVEDILOL REDUCES MORTALITY AND RENAL DAMAGE IN HYPERTENSIVESTROKE-PRONE RATS

      The Journal of pharmacology and experimental therapeutics
    89. KITADA Y
      BETAXOLOL, A BETA(1)-ADRENOCEPTOR ANTAGONIST, INHIBITS CA2-INDUCED CONTRACTION IN SKINNED RENAL-ARTERY OF THE DOG()

      Japanese Journal of Pharmacology
    90. NAKATANI K; KAWANABE Y; KATO A; TANAKA T
      INTERACTION OF PROPRANOLOL WITH S100 PROTEINS OF THE CARDIAC-MUSCLE

      European journal of pharmacology
    91. BRUNVAND H; FROYLAND L; HEXEBERG E; RYNNING SE; BERGE RK; GRONG K
      CARVEDILOL IMPROVES FUNCTION AND REDUCES INFARCT SIZE IN THE FELINE MYOCARDIUM BY PROTECTING AGAINST LETHAL REPERFUSION INJURY

      European journal of pharmacology
    92. CHENG HY; RANDALL CS; HOLL WW; CONSTANTINIDES PP; YUE TL; FEUERSTEIN GZ
      CARVEDILOL-LIPOSOME INTERACTION - EVIDENCE FOR STRONG ASSOCIATION WITH THE HYDROPHOBIC REGION OF THE LIPID BILAYERS

      Biochimica et biophysica acta. Biomembranes
    93. MEJEAN A; GUILLAUME JL; STROSBERG AD
      CARAZOLOL - A POTENT, SELECTIVE BETA(3)-ADRENOCEPTOR AGONIST

      European journal of pharmacology. Molecular pharmacology section
    94. JACOBSEN J; VANDEURS B; PEDERSEN M; RASSING MR
      TR146 CELLS GROWN ON FILTERS AS A MODEL FOR HUMAN BUCCAL EPITHELIUM .1. MORPHOLOGY, GROWTH, BARRIER PROPERTIES, AND PERMEABILITY

      International journal of pharmaceutics
    95. DEETJEN A; HEIDLAND A; PANGERL A; MEYERSABELLEK W; SCHAEFER RM
      ANTIHYPERTENSIVE TREATMENT WITH A VASODILATING BETA-BLOCKER, CARVEDILOL, IN CHRONIC-HEMODIALYSIS PATIENTS

      Clinical nephrology
    96. DOGGRELL SA; SURMAN AJ
      LOSS OF MAXIMUM ATTENUATION AND RECEPTOR RESERVE FOR ISOPRENALINE AT THE BETA(2)-ADRENOCEPTORS OF THE PORTAL VEINS OF HYPERTENSIVE RATS

      Journal of hypertension
    97. FEUERSTEIN GZ; RUFFOLO RR
      CARVEDILOL, A NOVEL MULTIPLE ACTION ANTIHYPERTENSIVE AGENT WITH ANTIOXIDANT ACTIVITY AND THE POTENTIAL FOR MYOCARDIAL AND VASCULAR PROTECTION

      European heart journal
    98. PATEL MK; CHAN P; BETTERIDGE LJ; SCHACHTER M; SEVER PS
      INHIBITION OF HUMAN VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION BY THE NOVEL MULTIPLE-ACTION ANTIHYPERTENSIVE AGENT CARVEDILOL

      Journal of cardiovascular pharmacology
    99. TRAUSCH B; OERTEL R; RICHTER K; GRAMATTE T
      DISPOSITION AND BIOAVAILABILITY OF THE BETA(1)-ADRENOCEPTOR ANTAGONIST TALINOLOL IN MAN

      Biopharmaceutics & drug disposition
    100. ANIYA Y; FONG KF; NAITO A; SAKANASHI M
      ANTIOXIDATIVE ACTION OF THE BETA-ADRENOCEPTOR ANTAGONIST BOPINDOLOL AND ITS METABOLITE-18-502

      Japanese Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 20:57:43